Intranasal Insulin for Alzheimer’s Disease

Brain insulin signaling contributes to memory function and might be a viable target in the prevention and treatment of memory impairments including Alzheimer’s disease. This short narrative review explores the potential of central nervous system (CNS) insulin administration via the intranasal pathwa...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	CNS drugs Jg. 35; H. 1; S. 21 - 37
1. Verfasser:	Hallschmid, Manfred
Format:	Journal Article
Sprache:	Englisch
Veröffentlicht:	Cham Springer International Publishing 01.01.2021 Springer Nature B.V
Schlagworte:	Administration, Intranasal Alzheimer Disease - drug therapy Alzheimer Disease - physiopathology Alzheimer's disease Animals Brain - drug effects Brain - physiopathology Central nervous system Clinical trials Cognition & reasoning Cognitive ability Cognitive Dysfunction - drug therapy Cognitive Dysfunction - physiopathology Female Humans Hypoglycemic Agents - administration & dosage Hypoglycemic Agents - pharmacology Hypothalamus Insulin Insulin - administration & dosage Insulin - pharmacology Insulin Resistance Male Medicine Medicine & Public Health Memory Memory - drug effects Neurodegenerative diseases Neurology Neurosciences Parkinson's disease Pharmacotherapy Pituitary Psychiatry Psychopharmacology Review Review Article Sex differences Sex Factors Sleep Synaptic plasticity United States > US
ISSN:	1172-7047, 1179-1934, 1179-1934
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!